Monopar Therapeutics shares began trading on the Nasdaq stock exchange.
4 reports, 3 independent
Updated Jul 24
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Monopar Therapeutics shares began trading on the Nasdaq stock exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Monopar Therapeutics
biopharmaceutical company
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
Related events
- Eliem Therapeutics, Inc. began trading on the Nasdaq stock exchange.
- Odyssey Therapeutics, Inc. shares are being traded on the Nasdaq exchange.
- Analyst ratings published on MarketBeat for Monopar Therapeutics, which trades on the Nasdaq stock exchange.
- Fulcrum Therapeutics and Slate Medicines announced a merger to advance next-generation therapeutics and will list on Nasdaq.
- Argenex SE and Capricor Therapeutics were listed on the Nasdaq stock exchange and are competing in the biotech sector.
Coverage
Newest first; wire copies grouped- tickerreport.com
- dailypolitical.comMonopar Therapeutics (NASDAQ:MNPR) Price Target Raised to $125.00
- themarketsdaily.com
- tickerreport.com